The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Authors:
Top Cited Papers
Open Access
- 13 September 2017
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 8, 1124
Abstract
Natural killer (NK) cells are innate immune cells that show strong cytolytic function against physiologically stressed cells such as tumor cells and virus-infected cells. NK cells show a broad array of tissue distribution and phenotypic variability. NK cells express several activating and inhibitory receptors that recognize the altered expression of proteins on target cells and control the cytolytic function. NK cells have been used in several clinical trials to control tumor growth. However, the results are encouraging only in hematological malignancies but not very promising in solid tumors. Increasing evidence suggests that tumor microenvironment regulate the phenotype and function of NK cells. In this review, we discussed the NK cell phenotypes and its effector function and impact of the tumor microenvironment on effector and cytolytic function of NK cells. We also summarized various NK cell-based immunotherapeutic strategies used in the past and the possibilities to improve the function of NK cell for the better clinical outcome.Keywords
This publication has 171 references indexed in Scilit:
- Sustained effector function of IL-12/15/18–preactivated NK cells against established tumorsJournal of Experimental Medicine, 2012
- Cancer immunoediting by the innate immune system in the absence of adaptive immunityJournal of Experimental Medicine, 2012
- Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and virusesNature Immunology, 2010
- Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicityProceedings of the National Academy of Sciences, 2009
- Natural killer cell cytotoxicity: how do they pull the trigger?Immunology, 2009
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinomaCancer Immunology, Immunotherapy, 2008
- Recognition of the Class Ib Molecule Qa-1b by Putative Activating Receptors Cd94/Nkg2c and Cd94/Nkg2e on Mouse Natural Killer CellsJournal of Experimental Medicine, 1999
- p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell ActivationJournal of Experimental Medicine, 1997
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985